Back Education
Education
Back Resources
Resources
Back About Us
About Us
an icon of a microscope, indicating research and science
Our Research Initiatives
Search
Nov 09, 2026 NIH Funds mRNA Research for Autoimmune Disease
NIH-funded researchers are developing mRNA nanoparticles designed to help the immune system tolerate specific antigens, potentially opening new avenues for treating autoimmune diseases without broad immunosuppression.
  • Autoimmune Diseases
  • Multiple Sclerosis
  • Research Studies
  • Rheumatoid Arthritis
  • Therapies
  • Type 1 Diabetes
Read Post
Nov 06, 2026 Measles Resurgence 2026: Experts Explain the Crisis
The United States is experiencing its worst measles resurgence in decades, with more than 5,000 cases reported in 2026 and growing concerns about vaccine confidence, public health preparedness, and the protection of vulnerable populations. The resurgence also raises important questions for people living with autoimmune disease, particularly those receiving treatments that suppress their immune systems. […]
  • Events
  • Risk Factors
Read Post
Oct 30, 2026 October 2026 OADR-ORWH Autoimmune Disease Research Update
During its October 29, 2026, quarterly update, the NIH Office of Autoimmune Disease Research (OADR) highlighted progress in research funding, data sharing, and earlier detection of autoimmune diseases. Discussions also addressed GLP-1 medications, the human immunome, co-occurring autoimmune conditions, and the potential implications of new federal women’s health initiatives.
  • Events
  • OADR (NIH Office of Autoimmune Disease Research)
  • Policy & Health Decisions
  • Sjögren disease
  • Type 1 Diabetes
Read Post
Oct 29, 2026 FNIH Celebrates 30 Years of Biomedical Research and Scientific Partnerships
The Foundation for the National Institutes of Health celebrated 30 years of biomedical research partnerships, recognizing NIAMS for its leadership in autoimmune research alongside scientific advances in neurological disorders, metabolism, and rare diseases.
  • Events
Read Post
Oct 28, 2026 Penn State EDS/HSD Conference to Explore Comorbidities and Research
The Penn State Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder Research Conference will take place on November 12, 2026, bringing together patients, caregivers, clinicians, researchers, and advocates to discuss the complex health conditions that frequently accompany Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders (HSD).
  • Events
Read Post
Oct 28, 2026 NIH Scientific Freedom Lecture: Key Takeaways
On October 28, 2026, the National Institutes of Health (NIH) hosted a Scientific Freedom Lecture featuring biostatistician and epidemiologist Martin Kulldorff, PhD. Titled Science Is Under Attack: How Can We Save It?, the presentation examined declining public trust in science, pandemic policies, vaccination, and scientific transparency. NIH Director Jay Bhattacharya, MD, PhD, introduced the lecture […]
  • Events
Read Post
Oct 22, 2026 GLP-1 Drugs and the Immune System: New Research on Autoimmune Disease
As GLP-1 medications become increasingly common, researchers are looking beyond their effects on blood sugar and weight to better understand how they influence the immune system. While previous studies suggest these medications may reduce inflammation, their effects on autoimmune disease remain uncertain. On October 21, 2026, the La Jolla Institute for Immunology (LJI) announced a new study […]
  • Research Studies
  • Therapies
Read Post
Oct 21, 2026 Applegate’s MS Misdiagnosis Highlights Challenges of Diagnosing Multiple Sclerosis
After five years of living with an MS diagnosis, Christina Applegate is searching for answers again. Her experience highlights why multiple sclerosis can be difficult to diagnose and the emotional impact of diagnostic uncertainty.
  • Autoimmune Stories
  • Diagnostic Testing
  • Multiple Sclerosis
Read Post